Literature DB >> 12145247

Role of hyperglycemia in nitrotyrosine postprandial generation.

Antonio Ceriello1, Lisa Quagliaro, Barbara Catone, Roberta Pascon, Marta Piazzola, Bruno Bais, Giampiero Marra, Laura Tonutti, Claudio Taboga, Enrico Motz.   

Abstract

OBJECTIVE: Recently, much attention has been paid to the possibility that postprandial hyperglycemia may be a cardiovascular risk factor in diabetes. Oxidative stress has been involved in the pathogenesis of diabetic complications, and increased plasma levels of nitrotyrosine, a product of peroxynitrite action, have been found in the plasma of diabetic subjects. The aim of the present study was to evaluate whether postprandial hyperglycemia is accompanied by nitrotyrosine generation and, if so, to explore a possible direct role of hyperglycemia in such a phenomenon. RESEARCH DESIGN AND METHODS: A total of 23 type 2 diabetic patients and 15 matched normal healthy subjects were recruited for this study. Two different tests were performed in diabetic patients: a standard meal preceded by regular insulin (0.15 units/kg body wt) or insulin aspart (0.15 units/kg body wt) to achieve different levels of postprandial hyperglycemia. The meal test was also performed in healthy control subjects. At 0 min and 1, 2, 4, and 6 h after each meal, blood glucose, triglyceride, and nitrotyrosine levels were measured.
RESULTS: Fasting nitrotyrosine was significantly increased in diabetic patients and was further increased during both meal tests in diabetic subjects but not normal subjects. As compared with regular insulin, aspart administration significantly reduced the area under the curve of both glycemia (P < 0.04) and nitrotyrosine (P < 0.03), whereas that of triglycerides was not significantly affected by the treatment.
CONCLUSIONS: This study shows a direct correlation between postprandial hyperglycemia and the production of nitrotyrosine, a marker of oxidative stress, in patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145247     DOI: 10.2337/diacare.25.8.1439

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  59 in total

Review 1.  Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy.

Authors:  L Monnier; C Colette; S Dejager; D R Owens
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

2.  Clinical performance of a device that applies local heat to the insulin infusion site: a crossover study.

Authors:  Guido Freckmann; Stefan Pleus; Antje Westhoff; Lars G Krinelke; Andreas Buhr; Nina Jendrike; Cornelia Haug
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

3.  Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.

Authors:  David A Zhang; Laurence Katznelson; Ming Li
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

4.  Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress.

Authors:  Simona Bo; Roberto Gambino; Marilena Durazzo; Sabrina Guidi; Elisa Tiozzo; Federica Ghione; Luigi Gentile; Maurizio Cassader; Gian Franco Pagano
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 5.  Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.

Authors:  Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

Review 6.  Average daily risk range as a measure for clinical research and routine care.

Authors:  Susana R Patton; Mark A Clements
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

7.  Analysis of the add-on effect of α-glucosidase inhibitor, acarbose in insulin therapy: A pilot study.

Authors:  Feng-Fei Li; Li-Yuan Fu; Xiao-Hua Xu; Xiao-Fei Su; Jin-Dan Wu; Lei Ye; Jian-Hua Ma
Journal:  Biomed Rep       Date:  2016-08-25

8.  Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.

Authors:  Alfredo Csibi; David Communi; Nathalie Müller; Serge P Bottari
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

Review 9.  Antioxidant anti-inflammatory treatment in type 2 diabetes.

Authors:  Antonio Ceriello; Roberto Testa
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations.

Authors:  A Ceriello; S Colagiuri
Journal:  Diabet Med       Date:  2008-10       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.